FRESENIUS KABI, LLC: $112M Department of Health and Human Services Contract
Summary
Fresenius Kabi, LLC, a private pharmaceutical manufacturer, received a $112M definitive contract from HHS/ASPR for bulk pharmaceutical supplies including acyclovir, doxycycline, meropenem, and saline solutions, supporting pandemic preparedness. No publicly traded companies are directly linked, but the award signals continued government investment in medical countermeasure stockpiling.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Fresenius Kabi, a private firm, secured a $112M multi-year contract for bulk pharmaceuticals, supporting HHS pandemic preparedness.
- 2.No publicly traded companies are directly tied to this award; investors lack a clear equity play.
- 3.The contract underscores ongoing federal spending on medical countermeasures, a tailwind for the healthcare sector broadly.
Market Implications
This contract does not directly move any publicly traded stock due to the private nature of Fresenius Kabi. However, the $112M award over five years signals sustained government demand for critical pharmaceuticals, which may indirectly benefit publicly traded contract manufacturing organizations (CMOs) or generic drug manufacturers if they serve as subcontractors. Without specific disclosure, no ticker can be named with confidence. The healthcare sector as a whole may see positive sentiment from continued biodefense spending, but this contract alone is not a catalyst for any individual company.
⚡ Government Convergence
This signal is one of the converging government actions below.
Over the last 90 days, 41 separate government actions have converged on Biodefense / Pandemic Preparedness. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 33 federal contracts, 6 procurement notices and 2 bills — it's the clearest early tell that Washington is committing to biodefense / pandemic preparedness, the kind of build-up that reshapes the sector well before it's obvious in the headlines.
Converging government actions
- BillBeagle Brigade Act of 2023 · 2024-12-23
- BillNo Flight, No Fight Act of 2026 · 2026-02-05
- ContractGLOBAL HEALTH INVESTMENT CORPORATION: OTHER TRANSACTION AGREEMENT: BARDA VENTURES · 2026-04-30
- Procurement noticeSources Sought Notice - Pandemic Preparedness Plan Evaluation · 2026-05-13
- Procurement noticeRFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections · 2026-05-21
- Procurement noticeRPP: BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-02
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-03
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-11
- ContractEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.: ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) · 2026-06-26
- Procurement noticePresolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response · 2026-07-30
- ContractSIGA TECHNOLOGIES, INC.: PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF · 2026-08-24
- ContractLUMINARY LABS LLC: BARDA OTHER TRANSACTION PRIZE VEHICLE · 2026-08-25
- ContractFRESENIUS KABI, LLC: $112M Department of Health and Human Services Contract · 2026-08-31
- BillBiosecurity Modernization and Innovation Act · 2026-08-31
Full Analysis
The Department of Health and Human Services, through the Office of Assistant Secretary for Preparedness and Response, awarded a $112M definitive contract to Fresenius Kabi, LLC for bulk pharmaceutical products including acyclovir sodium solution, doxycycline injection, meropenem, sodium chloride, and sterile water. The contract runs from March 2025 to March 2030, indicating a multi-year commitment to maintaining strategic reserves of critical medicines. Fresenius Kabi is a private entity, not a publicly traded company or recognized subsidiary of a public parent, so no direct ticker attribution is possible. The award falls under the broader biodefense and pandemic preparedness umbrella, which historically benefits the healthcare sector, particularly pharmaceutical manufacturers and distributors. However, without a public company recipient, retail investors cannot directly capitalize on this specific contract. The related bill signals provided show no direct legislative connection; most are neutral-impact bills on unrelated topics like land conveyances and procedural reforms. This contract is a routine but sizable investment in the pharmaceutical supply chain, reinforcing the government's role in ensuring availability of essential medicines during public health emergencies. Investors should monitor the sector for indirect effects, such as increased demand for raw materials or logistics services, but no specific tickers emerge from this award.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
BAXTER HEALTHCARE CORPORATION: $18.8M Department of Health and Human Services Contract
ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE): $264M Department of Health and Human Services Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Contract Details
Recipient
FRESENIUS KABI, LLC
Award Amount
$111,677,559
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →